IPCALABBSEIpca Laboratories LtdMinimalNeutral
Announced Wed, 27 May · 14:49 IST

The Company has encloseing herewith Annual Secretarial Companice Report for the FY 2025-26.

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.4%1-day move
₹1579.80
prior close
₹1573.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.1-0.2-0.0-5.4-6.5-4.5-1.8+2.5+4.1-2.2+4.0+13.1
Up moveDown movePending
AI summary

Ipca Laboratories Ltd has submitted its Annual Secretarial Compliance Report for the period ended March 31, 2026, certified by Parikh & Associates, Practicing Company Secretaries. The report examines compliance with SEBI regulations including LODR, Insider Trading Regulations, Takeover Regulations, and Depositories Regulations. The filing confirms the company generally complied with all applicable SEBI regulations during the review period with zero deviations or violations reported. No actions were taken by SEBI or stock exchanges against the company, its promoters, directors, or subsidiaries during the period. All 14 compliance checkpoints including secretarial standards, website disclosures, related party transactions, and insider trading norms show satisfactory compliance.

Likely market impact

This is a positive regulatory compliance update confirming Ipca Laboratories maintained full compliance with SEBI listing requirements. The clean certificate with zero deviations is reassuring for investors regarding corporate governance standards.